Kodiak Sciences (KOD) Non Operating Income (2017 - 2026)
Kodiak Sciences (KOD) reported Non Operating Income of -$22000.0 for Q1 2026, down 320.0% on a YoY basis from $10000.0 in Q1 2025, and up 45.0% quarter-over-quarter from -$40000.0 in Q4 2025.
Kodiak Sciences (KOD) Non Operating Income (2017 - 2026) Analysis & Trends
Kodiak Sciences has reported Non Operating Income for 10 years, with the latest figure at -$22000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 320.0% year-over-year to -$22000.0; the trailing twelve-month figure through Mar 2026 stood at -$128000.0 (up 19.5% YoY), and the FY2025 full-year result was -$96000.0, up 81.03% from the prior year.
- Non Operating Income for Q1 2026 stood at -$22000.0, up from -$40000.0 in the prior quarter.
- The five-year high for Non Operating Income was $605000.0 in Q4 2022, with the low at -$337000.0 in Q1 2024.
- Historically, Non Operating Income has averaged -$647.06 across 5 years, with a median of -$38000.0 in 2023.
- Annual changes were most pronounced in 2023 — Non Operating Income jumped 1807.69% — and 2026, when it plunged 320.0%.
- Kodiak Sciences' Non Operating Income stood at $605000.0 in 2022, then sank by 106.45% to -$39000.0 in 2023, then sank by 43.59% to -$56000.0 in 2024, then gained by 28.57% to -$40000.0 in 2025, then jumped by 45.0% to -$22000.0 in 2026.
- The last three Non Operating Income figures came in at -$22000.0 (Q1 2026), -$40000.0 (Q4 2025), and -$22000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 9.35 Mn |
| 10 | Kodiak Sciences | 1.92 Bn | 1.92 Bn | - | -22,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22,000.00 |
| Dec 31, 2025 | -40,000.00 |
| Sep 30, 2025 | -22,000.00 |
| Jun 30, 2025 | -44,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | -56,000.00 |
| Sep 30, 2024 | -25,000.00 |
| Jun 30, 2024 | -88,000.00 |
| Mar 31, 2024 | -337,000.00 |
| Dec 31, 2023 | -39,000.00 |
| Sep 30, 2023 | -38,000.00 |
| Jun 30, 2023 | -35,000.00 |
| Mar 31, 2023 | 222,000.00 |
| Dec 31, 2022 | 605,000.00 |
| Sep 30, 2022 | -40,000.00 |
| Jun 30, 2022 | -49,000.00 |
| Mar 31, 2022 | -13,000.00 |
| Dec 31, 2021 | -114,000.00 |
| Sep 30, 2021 | -25,000.00 |
| Jun 30, 2021 | -19,000.00 |